Anti-SARS-CoV-2 spike glycoprotein antibody [H6] - Human IgG1 (Chimeric)
- Recombinant
- What is this?
5
(3 Reviews)
|
(5 Publications)
Human Recombinant Monoclonal SPIKE antibody. Suitable for ELISA, WB, FuncS (Neut/Block) and reacts with SARS-CoV-2, SARS-CoV samples. Cited in 5 publications.
View Alternative Names
2, S, Spike glycoprotein, S glycoprotein, E2, Peplomer protein
- FuncS (Neut/Block)
Supplier Data
Functional Studies (Neut/Block) - Anti-SARS-CoV-2 spike glycoprotein antibody [H6] - Human IgG1 (Chimeric) (AB272854)
Binding signal of Anti-SARS-CoV-2 spike glycoprotein antibody [H6] - Human IgG1 (Chimeric) (ab272854) and SARS-CoV-2-S1-RBD was inhibited by ACE2 protein-HRP conjugated inhibitor with the IC50 23.32 nM.
- FuncS (Neut/Block)
Supplier Data
Functional Studies (Neut/Block) - Anti-SARS-CoV-2 spike glycoprotein antibody [H6] - Human IgG1 (Chimeric) (AB272854)
Binding signal of Anti-SARS-CoV-2 spike glycoprotein antibody [H6] - Human IgG1 (Chimeric) (ab272854) and SARS-CoV-2-S1-RBD was inhibited by ACE2 protein-HRP conjugated inhibitor with the IC50 2.38 μg/mL.
- ELISA
Supplier Data
ELISA - Anti-SARS-CoV-2 spike glycoprotein antibody [H6] - Human IgG1 (Chimeric) (AB272854)
Binding Activity of ab272854 with SARS-CoV-2-S1-RBD
Activity : Measured by its binding ability in a functional ELISA. Immobilized SARS-CoV-2-S1-RBD at 2 μg/ml can bind ab272854, the EC50 of SARS-CoV-2-S Antibody is 19.60-39.42 ng/ml.
- ELISA
Supplier Data
ELISA - Anti-SARS-CoV-2 spike glycoprotein antibody [H6] - Human IgG1 (Chimeric) (AB272854)
Binding Activity of ab272854 with SARS-CoV-2 spike glycoprotein.
Activity : Measured by its binding ability in a functional ELISA. Immobilized SARS-CoV-2 spike glycoprotein at 2 μg/ml can bind ab272854. The EC50 of ab272854 is 36.79-48.87 ng/ml.
- WB
Lab
Western blot - Anti-SARS-CoV-2 spike glycoprotein antibody [H6] - Human IgG1 (Chimeric) (AB272854)
Lanes 1 - 8 : Merged signal (red and green). Green - ab272854 observed at 200 kDa. Red - loading control.
ab272854 was shown to react with SARS-CoV-2 spike glycoprotein in western blot. Membranes were blocked in 3% milk before incubation with ab272854 overnight at 4°C at 1 ug/ml. Blots were incubated with Donkey anti-Mouse IgG H&L(IRDye® 800CW) preabsorbed (ab216774) antibody at 1 in 20000 dilution for 1 hour at room temperature before imaging.
Note : ab216774 is suitable for the recognition of the Mouse scFv fragment of ab272854.
All lanes:
Western blot - Anti-SARS-CoV-2 spike glycoprotein antibody [H6] - Human IgG1 (Chimeric) (ab272854) at 1 µg/mL
Lane 1:
Mock transfected Expi cell lysate at 10 µg
Lane 2:
PDL-1 Flag transfected Expi cell lysate at 10 µg
Lane 3:
SARS-Cov1 spike protein transfected Expi cell lysate at 10 µg
Lane 4:
SARS-Cov1 3xFlag spike protein transfected Expi cell lysate at 10 µg
Lane 5:
SARS-Cov2 spike protein transfected Expi cell lysate at 10 µg
Lane 6:
SARS-Cov2 3xFlag spike protein transfected Expi cell lysate at 10 µg
Lane 7:
MERS Spike protein transfected Expi cell lysate at 10 µg
Lane 8:
MERS 3xFlag Spike protein transfected Expi cell lysate at 10 µg
Observed band size: 200 kDa
false
Reactivity data
Product details
Anti-SARS-CoV-2 spike glycoprotein antibody [H6] - Human IgG1 (Chimeric) (ab272854) is a recombinant human/mouse chimeric monoclonal antibody consisting of Mouse scFv fused with human IgG1.
As the Fc region is human, an anti-Human secondary antibody should be used for detection. A suitable anti-Mouse secondary may also be used.
Properties and storage information
Form
Purity
Purification notes
Storage buffer
Shipped at conditions
Appropriate short-term storage duration
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Aliquoting information
Storage information
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
The SARS-CoV-2 Spike Glycoprotein initiates viral entry by interacting with the host cell's ACE2 receptor which leads to viral fusion and entry into the cell's cytoplasm. The protein is part of the virion structure and forms the visible spike on the virion's surface. Upon binding a conformational change triggers the fusion of viral and cellular membranes a vital step for the viral lifecycle. The multimeric nature of the Spike Protein facilitates its interaction with antibodies including those known as 'anti-spike antibodies' which can neutralize the virus and prevent cell infection.
Pathways
The Spike Glycoprotein plays a significant role in the viral infection process and immune response pathways. It is central to the receptor-mediated endocytosis pathway where the virus is internalized into host cells. The protein’s interaction with ACE2 modifies downstream signaling pathways potentially altering host cell functions. Related proteins in these pathways include the ACE2 receptor and the cellular protease TMPRSS2 which primes the Spike Protein for fusion and viral entry.
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Publications (5)
Recent publications for all applications. Explore the full list and refine your search
Heliyon 10:e30044 PubMed38698981
2024
Applications
Unspecified application
Species
Unspecified reactive species
Vaccines 11: PubMed38005972
2023
Applications
Unspecified application
Species
Unspecified reactive species
International journal of molecular sciences 23: PubMed36142365
2022
Applications
Unspecified application
Species
Unspecified reactive species
RSC advances 12:16184-16193 PubMed35733688
2022
Applications
Unspecified application
Species
Unspecified reactive species
Vaccines 10: PubMed35214708
2022
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com